137 Publications (Page 5 of 6)
2008
Addressing the challenges of a cross-national investigation: lessons from the Pittsburgh-Pisa study of treatment-relevant phenotypes of unipolar depression
Frank, EllenCassano, Giovanni BattistaRucci, PaolaFagiolini, AndreaMaggi, LucaKraemer, Helena CKupfer, David JPollock, Bruce GBies, R. RNimgaonkar, Vishwajit LPilkonis, Paul AShear, M. KThompson, WesleyGrochocinski, Victoria JScocco, PaoloButtenfield, Joan and Forgione, Rocco N
Clinical Trials, vol. 5, (no. 3), pp. 253-61, Jun 2008. | Journal Article
 
Anticholinergic Activity of 107 Medications Commonly Used by Older Adults
Chew, Marci LMulsant, Benoit HPollock, Bruce GLehman, Mark EGreenspan, AndrewMahmoud, Ramy AKirshner, Margaret ASorisio, Denise ABies, R. R and Gharabawi, Georges
Journal of the American Geriatrics Society, vol. 56, (no. 7), pp. 1333-1341, Jul 2008. | Journal Article
 
Incomplete response in late-life depression: getting to remission.
Lenze, Eric JSheffrin, MeeraDriscoll, Henry CMulsant, Benoit HPollock, Bruce GDew, Mary ALotrich, FrankDevlin, BernieBies, Robert and Reynolds, Charles F
Dialogues in clinical neuroscience, vol. 10, (no. 4), pp. 419-30, 2008. | Journal Article
 
Mathematics for understanding disease.
Bies, RobertGastonguay, M R and Schwartz, S L
Clinical pharmacology and therapeutics, vol. 83, (no. 6), pp. 904-8, 2008/Jun. | Journal Article
 
Pharmacokinetics in geriatric psychiatry.
Bigos, Kristin LChew, Marci L and Bies, Robert
Current psychiatry reports, vol. 10, (no. 1), pp. 30-6, 2008/Feb. | Journal Article
 
Population pharmacokinetic analysis for risperidone using highly sparse sampling measurements from the CATIE study.
Feng, Y.Feng, YanPollock, Bruce GPollock, B.G.Coley, K.Coley, KimMarder, S.Marder, StephenMiller, D.Miller, DelKirshner, MargaretKirshner, M.Aravagiri, ManickamAravagiri, M.Schneider, LonSchneider, L.Bies, R.R. and Bies, Robert
British journal of clinical pharmacology, vol. 66, (no. 5), pp. 629-39, 2008/Nov. | Journal Article
 
Sex, race, and smoking impact olanzapine exposure.
Bigos, Kristin LBigos, K.L.Pollock, Bruce GPollock, B.G.Coley, Kim CColey, K.C.Miller, Del DMiller, D.D.Marder, StephenMarder, S.R.Aravagiri, ManickamAravagiri, M.Kirshner, M.A.Kirshner, Margaret ASchneider, Lon SSchneider, L.S.Bies, R.R. and Bies, Robert
Journal of clinical pharmacology, vol. 48, (no. 2), pp. 157-65, 2008/Feb. | Journal Article
 
Suboptimal aminoglycoside dosing in critically ill patients.
Rea, Rhonda SCapitano, BlairBies, RobertBigos, Kristin LSmith, Randall and Lee, Howard
Therapeutic drug monitoring, vol. 30, (no. 6), pp. 674-81, 2008/Dec. | Journal Article
2007
A comparison of the pharmacokinetics and pharmacodynamics of docetaxel between African-American and Caucasian cancer patients: CALGB 9871.
Lewis, Lionel DMiller, Antonius XRosner, Gary LDowell, Jonathan EValdivieso, ManuelRelling, Mary VEgorin, Merrill JBies, RobertHollis, Donna RLevine, EllisOtterson, Gregory AMillard, Frederick and Ratain, Mark J
Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 13, (no. 11), pp. 3302-11, 2007/Jun/1. | Journal Article
2006
817: Combination Atrasentan-Taxane Therapy for Treatment of Prostate Cancer in Vitro and In Vivo
Akhavan, ArdavanGuruli, GeorgiMcHugh, KevinBies, Robert RReddy, Shivani TNelson, Joel B and Pflug, Beth
The Journal of Urology, vol. 175, (no. 4), pp. 264, April 2006. | Journal Article
 
A Genetic Algorithm-Based, Hybrid Machine Learning Approach to Model Selection
Bies, R. RMuldoon, MatthewPollock, BruceManuck, StevenSmith, Gwenn and Sale, Mark E
Journal of Pharmacokinetics and Biopharmaceutics, vol. 33, (no. 2), pp. 195-221, 2006. | Journal Article
 
A model of anticholinergic activity of atypical antipsychotic medications.
Chew, Marci LMulsant, Benoit HPollock, Bruce GLehman, Mark EGreenspan, AndrewKirshner, Margaret ABies, RobertKapur, Shitij and Gharabawi, Georges
Schizophrenia research, vol. 88, (no. 1-3), pp. 63-72, 2006/Dec. | Journal Article
 
Bjorkman S. Prediction of cytochrome p450-mediated hepatic drug clearance in neonates, infants, and children. How accurate are available scaling methods?
Bies, Robert
Journal of Clinical Pharmacology, vol. 46, (no. 9), pp. 1053, 20060901. | Journal Article
 
Brightman FA, Leahy DE, Searle GE, Thomas S. Application of a generic physiologically based pharmacokinetic model to the estimation of xenobiotic levels in rat plasma
Bies, Robert
Journal of Clinical Pharmacology, vol. 46, (no. 9), pp. 1054, 20060901. | Journal Article
 
Csajka C, Verotta D. Pharmacokinetic-pharmacodynamic modelling: history and perspectives
Bies, Robert
Journal of Clinical Pharmacology, vol. 46, (no. 9), pp. 1054, 20060901. | Journal Article
 
Development of a dosage strategy in patients receiving enoxaparin by continuous intravenous infusion using modelling and simulation.
Feng, YanFeng, Y.Green, BruceGreen, B.Duffull, Steve BDuffull, S.B.Kane Gill, S.L.Kane-Gill, Sandra LBobek, M.B.Bobek, Mary BBies, R.R. and Bies, Robert R
British journal of clinical pharmacology, vol. 62, (no. 2), pp. 165-76, 2006/Aug. | Journal Article
 
Endothelin receptor A blockade enhances taxane effects in prostate cancer.
Akhavan, ArdavanMcHugh, Kevin HGuruli, GeorgiBies, RobertZamboni, William CStrychor, Sandra ANelson, Joe B and Pflug, Beth
Neoplasia (New York, N.Y.), vol. 8, (no. 9), pp. 725-32, 2006/Sep. | Journal Article
 
Endothelin Receptor A Blockade Enhances Taxane Effects in Prostate Cancer1
Akhavan, ArdavanMchugh, Kevin HGuruli, GeorgiBies, Robert RZamboni, William CStrychor, SandraNelson, Joel B and Pflug, Beth R
Neoplasia (New York, N.Y.), vol. 8, (no. 9), pp. 732, 2006-09-01. | Journal Article
 
Hillman S, Mandrekar SJ, Bot BM, et al. Should attribution be considered when interpreting adverse event data: a North Central Cancer Treatment Group (NCCTG) investigation of a phase III placebo-controlled trial
Bies, Robert
Journal of Clinical Pharmacology, vol. 46, (no. 9), pp. 1054, 20060901. | Journal Article
 
Latz JE, Chaudhary A, Ghosh A, Johnson RD. Population pharmacokinetic analysis of ten phase II clinical trials of pemetrexed in cancer patients
Bies, Robert
Journal of Clinical Pharmacology, vol. 46, (no. 9), pp. 1052, 20060901. | Journal Article
 
Navarro VJ, Senior JR. Drug-related hepatotoxicity.(Brief article)
Bies, Robert
Journal of Clinical Pharmacology, vol. 46, (no. 9), pp. 1052, 20060901. | Journal Article
 
Paroxetine: population pharmacokinetic analysis in late-life depression using sparse concentration sampling.
Feng, YanPollock, Bruce GFerrell, Robert EKimak, Mark AReynolds, Charles F and Bies, Robert
British journal of clinical pharmacology, vol. 61, (no. 5), pp. 558-69, 2006/May. | Journal Article
 
Population Pharmacokinetics in Geriatric Psychiatry
Bigos, Kristin LBies, R. R and Pollock, Bruce G
The American Journal of Geriatric Psychiatry, vol. 14, (no. 12), pp. 993-1003, Dec 2006. | Journal Article
 
Protective effect of the 20-HETE inhibitor HET0016 on brain damage after temporary focal ischemia
Poloyac, M. SZhang, YuqingBies, R. RKochanek, Patrick M and Graham, Steven H
Journal of Cerebral Blood Flow and Metabolism, vol. 26, (no. 12), pp. 1551-1561, 2006. | Journal Article
 
Relevance of assessing drug concentration exposure in pharmacogenetic and imaging studies.
Lotrich, Francis EBies, RobertSmith, Gwenn and Pollock, Bruce G
Journal of psychopharmacology (Oxford, England), vol. 20, (no. 4 Suppl), pp. 33-40, 2006/Jul. | Journal Article